FALL 2023 HIGHLIGHTS |
 |
 |
 |
 |
 |
 |
 |
|
Welcome to the media page of Dr. Robert L. Bard. For all media outlets, news reporters, proposal agents, medical and educational institutions, this page is your first stop to provides complete access to all of Dr. Bard's resources, literary works, visual assets (photos & videos) and historical achievements. If there is something specific that you cannot find here, contact our access management team at: 212.355.7017 or email: bardcancercenter1@gmail.com.
 |
Robert L. Bard, MD, DABR, FAIUM, FASLMS is internationally recognized as a leader in the field of 21st Century 3-D ULTRASONOGRAPHIC VOLUMETRIC DOPPLER IMAGING. Dr. Bard specializes in advanced 3-D sonography to detect cancers in numerous organs including the breast, prostate, skin, thyroid, melanoma and other areas. Dr. Bard’s images are used to accurately guide biopsies, target therapy and provide focused follow-up after treatment. Dr. Bard’s medical career began as a diagnostic radiologist and evolved into the practice of non-invasive 3D imaging with ultrasound, MRI and laser technologies. He has served in the military, been the head Radiologist at several leading hospitals, and published a multitude of textbooks and scientific papers. He presents articles worldwide, teaches at International Conferences and is on the Editorial Review Board of National and International Medical Journals. Holding medical licenses in several states, he holds Board certification from the American Board of Radiology (1974) and Fellowship in the American Society of Lasers in Medicine and Surgery (2014)
Dr. Bard currently runs a private consulting practice in New York City. He appears frequently on regional television, national radio and is a consultant to major healthcare organizations. He is committed to improving non-invasive cancer testing and developing minimally invasive image guided technologies to prevent cancer spread through his foundation - The Biofoundation for Angiogenesis Research and Development. In his role as director of BARD CANCER DIAGNOSTICS, he lectures at Mt. Sinai Medical Center, NYU Medical Center and leading international hospitals in England, France, Spain and the Netherlands.
ABRIDGED BIO FOR ARTICLES:
ROBERT L. BARD, MD is internationally recognized in the field of 3D DOPPLER ULTRASOUND IMAGING to detect cancers (in organs including the breast, prostate, skin, thyroid, melanoma and other areas). As a certified diagnostic radiologist, Dr. Bard evolved his practice to pursue non-invasive 3D imaging with ultrasound, MRI and laser technologies. He is also passionate about conducting educational presentations and publishing in International Medical Journals. Dr. Bard currently holds various medical licenses (in NY, NJ, CT and FLa) and holds Board certification from the American Board of Radiology (1974) and Fellowship in the American Society of Lasers in Medicine and Surgery (2014).https://drrobertbard.com/ |
|
|
Book
Launch
.png)
|
2023 BOOK LAUNCH: "IMAGE GUIDED AESTHETIC PROCEDURES & TREATMENTS"
 |
10/21/2023 - After two years in the making, we congratulate Dr. Robert Bard and his alliance of clinical experts for the launch of "IMAGE GUIDED AESTHETIC PROCEDURES & TREATMENTS". Springer Medical Publishing proudly presents the first installment in clinical aesthetic procedures. This detailed and up-to-date overview of image-guided procedures focuses on the many aesthetic and reconstructive strategies delivered by some of today's renowned leaders in the clinical aesthetics community. They share their valuable expertise and field-based findings throughout this feature-rich textbook. The wide list of audiences for this text (ie. dermatologists, plastic surgeons, aestheticians, general surgeons) will enjoy an insider's look at each treatment program while providing remarkable field-based knowledge for the general non-medical audience seeking the latest information in non-invasive and minimally invasive aesthetic procedures. (see press feature) |
|
Research
Updates
|
2023 NON-INVASIVE RESEARCH CLINIC
8/16/2023 - In great support of a the global movement of NON-INVASIVE medicine, we proudly introduce the INTEGRATIVE HEALTH RESEARCH CENTER by AngioInnovation Research (501c3). This New York city-based diagnostic imaging validation lab is established to clinically identify the efficacy, performance and supportive claims set by non-invasive therapeutics and diagnostic solutions. Co-founded by Dr. Robert L. Bard, the IHRC offers a non-profit, non-commercialized testing option for health-related innovations who seek an independent and impartial reporting through single-case pilot studies or IRB-Based clinical trials. The IHRC employs credentialed medical professionals and specialists in clinical research whose experience contributes to the unique strategic approach of each test study. (click to review latest research reports) |
Cancer
News |
HEADLINE NEWS: DR BARD IS CALLED AS MEDICAL EXPERT IN 'SPOTLIGHT ON AMERICA" FEATURE ON DENSE BREAST RESEARCH REPORT
 |
10/14/2022 - Millions of women have this breast cancer risk factor... why aren't they being informed? NEW YORK (TND) — This Breast Cancer Awareness Month, Spotlight on America is pressing to ensure women have access to a crucial health fact that could save their lives. According to the Centers for Disease Control and Prevention, 40% of women have dense breast tissue, which is a risk factor for cancer. Our team first highlighted this issue in October 2021, and more than a year later, we expose how some women are still being left in the dark about their density, and federal health bodies are failing to make sure they’re informed. Suzanne McDonald was 48 years old when she got a routine mammogram in 2007. Like so many women, she received a letter telling her the X-ray was clear, and she breathed a sigh of relief. McDonald threw her letter in the garbage, trusting that it told her all she needed to know. She’d later find out that the mammogram had missed what was happening in her body: late-stage 3C cancer, which had been concealed by extremely dense breast tissue, which McDonald had never heard of. [Original TND Link | Backup video link } |
| Special Annc: |
A YEAR OF RECOGNITION FOR A LEGACY OF ACADEMIC VISION, MEDICAL INNOVATION AND ADVOCACY IN CANCER DIAGNOSTICS 6/25/2022- Having received several lifetime achievement awards in one year is indicative of the vast achievements of Dr. Robert Bard. He is celebrated in major circles for his countless clinical findings and his unending drive to advance the medical and academic communities to support integrative health sciences and the non-invasive movement. Starting with his credentials as a cancer imaging specialist, Dr. Bard is also heavily committed to a bevy of critical roles in the future of patient care including: validation research, education in non-invasive modalities for the medical community, technical advisor to countless health organizations and a nationally recognized advocate for firefighters' safety against environmental toxic exposures. Dr. Bard attributes his career in radiology to the US Air Force, having served in military hospitals in Thailand and Laos in the early ‘70’s. There, he witnessed the critical demands for immediate response and real-time diagnostic technology where time and accuracy are of the ultimate essence. This started him on a multi-track life plan to help advance diagnostic technologies to endure 'battle hardened' challenges of a military hospital setting all the way to our emergency responders and the ICU of today. (Click to access feature story) |
Association
Updates
|
AIUM NEWS: DR BARD ELECTED IN 6-YEAR LEADERSHIP ROLES WITH NATIONAL ULTRASOUND ASSOCIATION
 |
7/28/2022 - Members of the American Institute of Ultrasound in Medicine (AIUM) have elected a new slate of leaders to the Executive Committee, Board of Governors, and Communities. These leaders will work to support the AIUM’s mission to empower and cultivate a global multidisciplinary community engaged in the use of medical ultrasound through raising awareness, education, sharing information, and research. DR. ROBERT L. BARD (Diagnostic Imaging Specialist, NYC) was recently elected Secretary of the Therapeutic Ultrasound Community. He will serve a 2-year term as Secretary, a 2-year term as Vice Chair, and a 2-year term as Secretary. The AIUM's mission is to empower and cultivate a global multidisciplinary community engaged in the use of medical ultrasound through raising awareness, education, sharing information, and research. "The AIUM values the individual members who volunteer their time, talents, and expertise to ensure we address the needs of the ultrasound community," said AIUM CEO Glynis Harvey, CAE. "Dr Bard joins a leadership team dedicated to improving the value of the AIUM and we look forward to his contributions." |
|
| |
|
| Resources |
 |
|
|
|
BardVideos.com |
 |
 |
 |
|
|
|
ART: Posters, & Flyers
|
|
Research Reports
|
|
| Articles |
|
| |
CV versions
|
|
|
| Recent Programs |
• Women's Diagnostic Network
• PediatricScan.com
• Mommies on a Mission
• Post Military Crusaders Coalition
• MedTech Reviews
• PEMF Features 1 | 2 | 3 | 4 | 5
• Shockwave Features 1
|
LATEST NEWS
• Ellis Island Award
• Fire Academy Commemoration
• Video: Chief Halton on Dr. Bard
• Video Teaser: Reuters Health
• Responder Resilience (1975)
• TBD |
|
Image
Assets
|
| Click thumbnails to enlarge and download |
 |
 |
 |
 |
 |
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
Latest Feature
|
Sept/Oct 2023 |
FULL-BODY IMAGING MOVEMENT: THE STRATEGIC UPGRADE OF THE MRI-
Written by Robert L. Bard, MD & Lennard M. Gettz, Ed.D
Since the advent of the magnetic resonance imaging (MRI) exam on human patients (late 1970’s), this innovation offered a multi-layered and noninvasive approach to imagining of bodily organs, functions and the ability to diagnose disease. The MRI design applies the use of a radio frequency and a large magnet to generate visual reports of structures inside the body to monitor a major set of conditions. The classic design of the MRI is recognized as one of the few non-invasive modalities that allow in vivo evaluation of the brain without radiation. For this, the development of the MRI was widely applied in adult imaging studies of abnormal cognition and behavior. Its popularity is due to its ability to quantify neurobiological features throughout the brain including brain structure, the measure of neurotransmitters and the detection of hemodynamics (blood flow measurement). - (See interactive online issue | See PDF of this article)
|
|
 |
DIGITAL IMAGING FOR PELVIC FLOOR DISORDERS
By: Roberta Kline, MD And Robert L. Bard, MD, DABR, FASL
The use of digital imaging in the diagnosis and management of pelvic floor disorders in women. 9/15/2022- Pelvic floor disorders arise from injury to and/or dysfunction of the muscles or connective tissues that result in a variety of conditions, with the most common being pelvic organ prolapse and urinary and fecal incontinence. Women with significant pelvic floor dysfunction have a lower quality of life, and also are more likely to have their sexual function impacted. Not included under this umbrella term are other issues of the pelvic floor related to non-relaxation, so in reality the numbers given previously are even higher. Underlying causes include genetic predispositions and inherited diseases of connective tissue, vaginal birth, surgical procedures, sexual trauma, obesity, chronic constipation and other lifestyle factors. (See article) |
|
 |
CANCER DIAGNOSTIC EXPERT, ITN EDITORIAL ADVISORY BOARD MEMBER ROBERT BARD, MD, RECEIVES THE PRESTIGIOUS ELLIS ISLAND MEDAL OF HONOR
May 19, 2022 — Robert L. Bard, M.D., an ITN editorial advisory board member, received one of the highest achievements of his career; the prestigious 35th Annual Ellis Island Medals of Honor. Alongside a list of over 80 top American achievers, this historical ceremony which took place at the Ellis Island Great Hall celebrated inspiring Americans who are selflessly worked for the betterment of our country and its citizens. In the spring of 2020, the Ellis Island Honor Society officially recognized Dr. Bard for his life’s work in clinical and research contributions in diagnostic imaging detection of cancers. The annual tradition of this nation’s most prestigious awards to honor American achievers has been upheld since 1986- but experienced its first postponement due to the devastating impact of the Coronavirus Pandemic. Both the 2020 and 2021 events had been postponed to this year, where significant new support and an impressive lineup re-ignited the continuance of event. (see complete article)
|
|
 |
2021 REVIEW: TRANSCRANIAL DOPPLER ULTRASOUND IMAGING
The ultrasound design using sound waves and echo reflection became widely accepted for being the safe (non-radiation), inexpensive, repeatable and non-invasive alternative in medical imaging. Early clinical upgrades included the development of the pulse Doppler paradigm (1966) to enable scanning layers of the heart via blood flow. From pediatric scanning to its expansion of the 3D Doppler Ultrasound to the noteworthy advantages of TCD (Transcranial Doppler), innovations continue to place the ultrasound in more areas of research and patient care. (See article) |
|
 |
USE OF ULTRASOUND IN A 2021 RESEARCH STUDY OF BREAST DENSITY
In an ongoing clinical study co-investigated by Dr. Robert Bard (NYC) and Dr. Noelle Cutter (of Molloy College, Long Island, NY), data is collected from a cohort of women undergoing ultrasound density scans. Inspired by Dr. Cappello’s early surveys of specific demographic groups, this 2021 research explores dense breast predominance in the younger population or those with lower body mass index (including dancers and athletes), both are likely candidates to receive false negative readings on a mammogram. -Download Dr. Bard's feature segment | see ITN full issue
|
|
 Shortcut link to Dr. Bard's article pgs 18-21 |
NOVEMBER / DECEMBER 2020 ISSUE
Dr. Bard's latest article on "Recognizing Covid-19 on 3D Ultrasound of the Pleural Lining" is featured on pgs 18-21 of RADIOLOGY TODAY. " Imaging of the lung is functionally divided into outpatient, noncritical patients and acutely ill patients- or those suspected of infectious disorders. Contagious conditions such as Covid-19 require equipment that is easily sanitized or disposable. Handheld units and disposable gel packets are preferred in potentially contaminated circumstances".
<See COMPLETE INTERACTIVE MAGAZINE- link> |
|
 |
PAVING MEDICAL HISTORY FROM THE FRONT LINES: THE ULTRASOUND MOVEMENT - From a military call of duty in Thailand (1921) to a Post-9/11 First Responders Cancer Screening program to the first Covid-19 triage units in Italy, ultrasound imaging has evolved to support medical diagnostic needs of all FRONT LINES. Both Dr. Robert Bard and the many scanning benefits of ultrasound technology have dedicated an entire work history of responding to some of the highest demands in emergency scanning (See Feature article) |
|
FLORIDA CONDO COLLAPSE DISASTER CALLS FOR FIELD DIAGNOSTIC DEPLOYMENT (PDF)
7/24/2021- With respect to victims trapped by settling wreckage, tissue damage is diagnosable and the site for appropriate triage and definitive treatment may be planned expediently. Advanced military targeting cybernetics that allowed Israeli jets to selectively pinpoint a terrorist cell in the middle of an 11-story high rise complex was used to relocate the probable escape routes of the potential survivors during the recent building collapse in Surfside, Florida. Chief Medical Advisor Dr. Robert Bard features a comprehensive review on today's point of care field ultrasound scanning technology and its advantages in rescue calls. (See complete article in Fire Engineering) |
| |
|
|
NEWS/ Congrats |
|
ITN- IMAGING TECHNOLOGY NEWS NOMINATES DR. ROBERT BARD TO THEIR 2022 EDITORIAL ADVISORY BOARD
Imaging Technology News (ITN) reaches more than 34,000 radiology, radiation oncology, women's health and nuclear medicine professionals. In addition to commanding the biggest share of market, ITN, with its detailed product comparison charts, is the resource buying team members use for specifying, recommending and authorizing technology purchases. Its award-winning editorial/design team has been honored most recently as a 2020 Jesse H. Neal Award Finalist for Best Technical Content. "We welcome Dr. Robert Bard to ITN’s new editorial advisory board members for 2022. These experts have been regular contributors to ITN, and we welcome their expertise and shared knowledge. Be sure to look for future articles, podcasts and editorial roundtables from them, and other key opinion leaders." |
|
|
| Headlines |
 |
DR. BARD ELECTED AS CHIEF MEDICAL ADVISOR FOR NATIONAL INITIATIVE: F.A.C.E.S. (Firefighters Against Cancer and Exposures). 4/14/2021- Leading the global front of this helping hand means searching for all available RESOURCES. FACES bands together as a community to form a solid support resource system between all cancer organizations and firefighter support groups. F.A.C.E.S. expands a community of resources dedicated to helping firefighters who have been diagnosed with cancer. (visit website) |
|
 |
THE 2021 CANCER POWERMEET SERIES: OCCUPATIONAL HEALTH RISKS
4/4/2021 - Dr. Bard kicked off the first I.C.R.A. town-hall style conference covering the topics of OCCUPATIONAL TOXIC EXPOSURES and SURVIVORSHIP AFTER THE JOB with prominent members of the NY First Responders' community as part of the "Get Checked Now!" program (see article) |
|
 |
GOING GLOBAL WITH NYCRA-NEWS: 3/15/2021 - Dr. Bard presents the first multi-nation seminar in support of global information. NYCRA-TV is forming international partnerships and alliances starting with our first Italian translated video of our top NYC cancer diagnostic expert Dr. Robert Bard with this trailer from his 2021 presentation on cancer diagnostic innovations. (SEE video clip). |
|
|
| |
|
|
Other News
|
|
|
| Media
|
|
|
Feature Stories
Pertaining to Dr. Bard's clinical programs or public projects |
|
|
| Press Releases |
|
Published Articles
Recent writing works
by Dr. Bard |
|
Events
|
|
|
Screening Programs
|
|
|
| Social Media |
|
|
| Newsletter |
| These are some of the most recent articles written by, with or about Dr. Bard - posted in social media and/or in one of various BCD endorsed newsletters. |
|
|
|
|
| |
|
|
| Foundation |
|
| Ads |
|
|
Associations
|
|
|
| |
 |
|
| Contact |
Bard Cancer Diagnostics | 121 E 60th St. #6A New York, NY | (212) 355-7017 |
|
|
.jpg)
